ISU CHEMICAL CO.,LTD
Financials
Valuation Metrics
ISU CHEMICAL CO.,LTD's Market Cap is ₩2380B. At end of 2025 it was ₩2172B. Ranked #733 of 2,410 in KR market (top 30%), #414 of 779 on KOSPI (top 53%), #83 of 293 in Materials (top 28%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 237.96B KRW | KR#733/2,410 Sec#83/293 |
| Revenue | 2.30T KRW | KR#232/2,410 Sec#27/293 |
| Net Income | 76.67B KRW | KR#307/2,410 Sec#34/293 |
| Total Assets | 1.05T KRW | KR#473/2,410 Sec#72/293 |
| Net Assets | 417.68B KRW | KR#582/2,410 Sec#95/293 |
| Employees | 307 | KR#773/2,410 Sec#90/293 |
| Value | ||
| P/E | 3.10x | KR#179/2,410 Sec#23/293 |
| P/B | 0.57x | KR#971/2,410 Sec#180/293 |
| P/S | 0.10x | KR#157/2,410 Sec#24/293 |
| EV/EBITDA | 1.69x | KR#42/2,410 Sec#2/293 |
| FCF Yield | -10.44% | KR—/2,410 Sec—/293 |
| Profitability | ||
| ROE | 18.36% | KR#207/2,410 Sec#13/293 |
| ROA | 7.31% | KR#489/2,410 Sec#44/293 |
| Op. Margin | 5.44% | KR#906/2,410 Sec#92/293 |
| Revenue Growth | 37.28% | KR#302/2,410 Sec#18/293 |
| Financial Health | ||
| Debt Ratio | 151.10% | KR#1,900/2,410 Sec#253/293 |
| Total Debt | 58.09B KRW | KR#944/2,410 Sec#153/293 |
| FCF | -24.85B KRW | KR#1,938/2,410 Sec#236/293 |
| Cash | 84.37B KRW | KR#532/2,410 Sec#67/293 |
| Current Ratio | 1.17x | KR#1,528/2,410 Sec#192/293 |
| Net Debt/EBITDA | -0.21x | KR#566/2,410 Sec#53/293 |
| Performance | ||
| 1Y Return | -15.18% | KR#1,107/2,410 Sec#145/293 |
| 1M Return | -21.44% | KR#2,030/2,410 Sec#253/293 |
| From 52W High | -49.69% | KR#1,219/2,410 Sec#173/293 |
| 1Y MDD | -47.72% | KR#874/2,410 Sec#121/293 |
| Trading | ||
| Volume | 346,705 shares | KR#429/2,410 Sec#31/293 |
| Trading Value | 3.17B KRW | KR#493/2,410 Sec#43/293 |
| Foreign Own. | 6.02% | KR#727/2,410 Sec#70/293 |
| Per Share | ||
| EPS | 2,916 KRW | KR#347/2,410 Sec#42/293 |
| BPS | 15,885 KRW | KR#663/2,410 Sec#113/293 |
Company Info
Headquartered in Seocho-gu, Seoul, Isu Chemical was established in 1969, engaging in petrochemical product manufacturing, subsidiary construction, and biopharmaceutical businesses. Its petrochemical division produces synthetic detergent raw materials such as LAB, NP, and LAS, while the construction division operates as a general construction company under the Brownstone apartment brand. The pharmaceutical division markets various biosimilar medicines and is pursuing the commercialization of high value-added products and an overseas smart farm export model.